EANS-Adhoc: Marinomed Biotech AG: aws Mittelstandsfonds and Invest AG sold Marinomed shares by way of an accelerated bookbuilding for EUR 95 per share to institutional investors Read more
EANS-Adhoc: Marinomed Biotech AG: aws Mittelstandsfonds und Invest AG haben Marinomed-Aktien im Wege eines Accelerated Bookbuildings zum Preis von je EUR 95 an institutionelle Investoren veräußert Read more
EANS-Adhoc: Marinomed Biotech AG: aws Mittelstandsfonds and Invest AG start partial sale of Marinomed shares by way of an accelerated bookbuilding Read more